258 related articles for article (PubMed ID: 9814431)
1. MR appearance of endometrial carcinoma and mucinous cystadenoma in a postmenopausal patient treated with tamoxifen for breast cancer.
Joja I; Asakawa T; Ando Y; Shiraiwa M; Shibutani O; Akaki S; Kuroda M; Mizutani Y; Kudo T; Hiraki Y
Radiat Med; 1998; 16(4):315-9. PubMed ID: 9814431
[TBL] [Abstract][Full Text] [Related]
2. [MR Imaging of the pelvis in the diagnosis of the endometrium in breast cancer patients in tamoxifen therapy].
Hauth E; Libera H; Kimmig R; Forsting M
Rofo; 2006 Mar; 178(3):316-23. PubMed ID: 16508840
[TBL] [Abstract][Full Text] [Related]
3. Adenofibroma of the endometrium after tamoxifen therapy for breast cancer: MR findings.
Oshima H; Miyagawa H; Sato Y; Satake M; Shiraki N; Nishikawa H; Arakawa A; Ogino H; Hara M
Abdom Imaging; 2002; 27(5):592-4. PubMed ID: 12173004
[TBL] [Abstract][Full Text] [Related]
4. Endometrial changes with chronic tamoxifen use.
Loret de Mola JR
Curr Opin Obstet Gynecol; 1997 Jun; 9(3):160-4. PubMed ID: 9263698
[TBL] [Abstract][Full Text] [Related]
5. Ovarian endometrioid carcinoma and endometriosis developing in a postmenopausal breast cancer patient during tamoxifen therapy: a case report and review of the literature.
Cohen I; Altaras MM; Lew S; Tepper R; Beyth Y; Ben-Baruch G
Gynecol Oncol; 1994 Dec; 55(3 Pt 1):443-7. PubMed ID: 7835785
[TBL] [Abstract][Full Text] [Related]
6. Secretory endometrial adenocarcinoma in a tamoxifen user with breast cancer after menopause.
Wu CJ; Peng YJ; Yu MH; Chen CH
Taiwan J Obstet Gynecol; 2007 Mar; 46(1):88-90. PubMed ID: 17389201
[No Abstract] [Full Text] [Related]
7. Asymptomatic carcinoma of the endometrium in a patient on adjunctive tamoxifen therapy for carcinoma of the breast.
O'Neill E; Rodríguez Mojica W
Bol Asoc Med P R; 1992 Feb; 84(2):74-7. PubMed ID: 1388459
[TBL] [Abstract][Full Text] [Related]
8. Indication of hysteroscopy in tamoxifen treated breast cancer patients.
Taponeco F; Curcio C; Fasciani A; Giuntini A; Artini PG; Fornaciari G; Petraglia F; Genazzani AR
J Exp Clin Cancer Res; 2002 Mar; 21(1):37-43. PubMed ID: 12071527
[TBL] [Abstract][Full Text] [Related]
9. Effects of tamoxifen therapy on the expression of p27 protein in the endometrium of women with primary breast cancer.
Siufi AA; Cotrim G Da Silva ID; De Cassia M Dardes R; Takita LC; Rodrigues De Lima G; Gonçalves WJ
Int J Oncol; 2003 Dec; 23(6):1545-51. PubMed ID: 14612925
[TBL] [Abstract][Full Text] [Related]
10. Endometrial polyps: a comparison study of patients receiving tamoxifen with two control groups.
Schlesinger C; Kamoi S; Ascher SM; Kendell M; Lage JM; Silverberg SG
Int J Gynecol Pathol; 1998 Oct; 17(4):302-11. PubMed ID: 9785130
[TBL] [Abstract][Full Text] [Related]
11. Outcomes in patients with primary breast cancer and a subsequent diagnosis of endometrial cancer : comparison of cohorts treated with and without tamoxifen.
Saadat M; Truong PT; Kader HA; Speers CH; Berthelet E; McMurtrie E; Olivotto IA
Cancer; 2007 Jul; 110(1):31-7. PubMed ID: 17510927
[TBL] [Abstract][Full Text] [Related]
12. Detection of endometrial cancer in asymptomatic postmenopausal breast cancer patient treated with tamoxifen: a case report.
Sinawat S; Chiyabutra T; Kleabkaew P
J Med Assoc Thai; 2001 Jul; 84(7):1033-6. PubMed ID: 11759963
[TBL] [Abstract][Full Text] [Related]
13. Granulosa cell tumor of the ovary associated with antecedent tamoxifen use.
Gherman RB; Parker MF; Macri CI
Obstet Gynecol; 1994 Oct; 84(4 Pt 2):717-9. PubMed ID: 9205462
[TBL] [Abstract][Full Text] [Related]
14. Gynecologic tumors in tamoxifen-treated women with breast cancer.
Seoud MA; Johnson J; Weed JC
Obstet Gynecol; 1993 Aug; 82(2):165-9. PubMed ID: 8393156
[TBL] [Abstract][Full Text] [Related]
15. [Primary multiple neoplasm of the endometrium and adjuvant hormone therapy in patients with breast cancer].
Bakhidze EV; Maksimov SIa; Barash NIu; Berstein LM; Semiglazov VF; Sheĭko EV; Novik VI
Vopr Onkol; 1998; 44(2):170-4. PubMed ID: 9615821
[TBL] [Abstract][Full Text] [Related]
16. MR imaging appearance of the uterus in postmenopausal women receiving tamoxifen therapy for breast cancer: histopathologic correlation.
Ascher SM; Johnson JC; Barnes WA; Bae CJ; Patt RH; Zeman RK
Radiology; 1996 Jul; 200(1):105-10. PubMed ID: 8657895
[TBL] [Abstract][Full Text] [Related]
17. [Uterine pathology in women with breast cancer treated with tamoxifen].
Carcangiu ML
Pathologica; 1997 Jun; 89(3):223-33. PubMed ID: 9380417
[No Abstract] [Full Text] [Related]
18. Co-occurrence of atypical endometriosis, subserous uterine leiomyomata, sactosalpinx, serous cystadenoma and bilateral hemorrhagic corpora lutea in a perimenopausal adipose patient taking tamoxifen (20 mg/day) for invasive lobular breast cancer.
Ebert AD; Rosenow G; David M; Mechsner S; Magalov IS; Papadopoulos T
Gynecol Obstet Invest; 2008; 66(3):209-13. PubMed ID: 18645252
[TBL] [Abstract][Full Text] [Related]
19. Endometrial cancer and tamoxifen.
Burke C
Clin J Oncol Nurs; 2005 Apr; 9(2):247-9. PubMed ID: 15853168
[No Abstract] [Full Text] [Related]
20. Endometrial carcinoma following treatment for breast carcinoma in a Nigerian female. A case report and review of the literature.
Abudu EK; Musa O; Adefuye PO; Abdul Kareem FB; Agboola AO; Banjo AA
Niger Postgrad Med J; 2007 Dec; 14(4):355-7. PubMed ID: 18163149
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
